Biophysical and immunological characterization of the ESX-4 system ESAT-6 family proteins Rv3444c and Rv3445c from Mycobacterium tuberculosis H37Rv

被引:9
作者
Pandey, Himanshu [1 ]
Fatma, Farheen [1 ]
Yabaji, Shivraj M. [3 ,4 ]
Kumari, Meera [1 ,4 ]
Tripathi, Sarita [1 ]
Srivastava, Kanchan [2 ]
Tripathi, Dinesh K. [3 ]
Kant, Surya [2 ]
Srivastava, Kishore K. [3 ]
Arora, Ashish [1 ]
机构
[1] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India
[2] King Georges Med Univ, Dept Resp Med, Lucknow, Uttar Pradesh, India
[3] Cent Drug Res Inst, CSIR, Microbiol Div, Lucknow 226031, Uttar Pradesh, India
[4] Acad Sci & Innovat Res AcSIR, New Delhi 110025, India
关键词
T-CELL RESPONSES; NECROSIS-FACTOR-ALPHA; COMPLEX-FORMATION; IFN-GAMMA; MOLECULAR CHARACTERIZATION; ESAT-6-CFP-10; COMPLEX; STIMULATED MONOCYTES; IMMUNE-RESPONSE; ANTIGENS ESAT-6; TNF-ALPHA;
D O I
10.1016/j.tube.2018.02.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ESAT-6 family proteins of Mycobacterium tuberculosis are regarded as the key mediators in mycobacterial virulence and are largely considered as antigens that can improve TB vaccines and diagnostics. We have characterized Rv3444c and Rv3445c proteins of the ESX-4 system of ESAT-6 family of M. tuberculosis H37Rv, and have experimentally established that these two proteins interact to form a heterodimeric complex. Complex formation resulted in induction of a-helical conformation and stability against chemical denaturation. To evaluate the immunogenic potential, we have immunized mice with Rv3444c or Rv3445c along with Freund's incomplete adjuvant (FIA). Immunization with Rv3444c-FIA or Rv3445c-FIA resulted in long term humoral responses. Re-stimulation of splenocytes from immunized mice resulted in significant lymphocyte proliferation with induction of TNF-alpha and IL-6. Further, the humoral responses to Rv3444c and Rv3445c antigens in Indian patients with active pulmonary TB (n = 44), and healthy individuals (n = 20), were investigated. Compared to healthy individuals, high levels of IgG against Rv3444c and Rv3445c were observed in TB patient's sera, indicating that these proteins are actively produced during the active phase of TB. Cellular immune responses to these proteins in active pulmonary TB patients (n = 5) were also investigated using peripheral blood mononuclear cells (PBMCs). Both the proteins induce significant lymphocyte proliferation and up-regulate the induction of TNF-alpha and IL-6 in TB patients.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 55 条
  • [21] IL-6: from its discovery to clinical applications
    Kishimoto, Tadamitsu
    [J]. INTERNATIONAL IMMUNOLOGY, 2010, 22 (05) : 347 - 352
  • [22] Lethal tuberculosis in interleukin-6-deficient mutant mice
    Ladel, CH
    Blum, C
    Dreher, A
    Reifenberg, K
    Kopf, M
    Kaufmann, SHE
    [J]. INFECTION AND IMMUNITY, 1997, 65 (11) : 4843 - 4849
  • [23] Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine
    Leal, IS
    Smedegård, B
    Andersen, P
    Appelberg, R
    [J]. INFECTION AND IMMUNITY, 1999, 67 (11) : 5747 - 5754
  • [24] Molecular features governing the stability and specificity of functional complex formation by Mycobacterium tuberculosis CFP-10/ESAT-6 family proteins
    Lightbody, Kirsty L.
    Ilghari, Dariush
    Waters, Lorna C.
    Carey, Gemma
    Bailey, Mark A.
    Williamson, Richard A.
    Renshaw, Philip S.
    Carr, Mark D.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) : 17681 - 17690
  • [25] Characterisation of complex formation between members of the Mycobacterium tuberculosis complex CFP-10/ESAT-6 protein family:: towards an understanding of the rules governing complex formation and thereby functional flexibility
    Lightbody, KL
    Renshaw, PS
    Collins, ML
    Wright, RL
    Hunt, DM
    Gordon, SV
    Hewinson, RG
    Buxton, RS
    Williamson, RA
    Carr, MD
    [J]. FEMS MICROBIOLOGY LETTERS, 2004, 238 (01) : 255 - 262
  • [26] A Functional Role for Antibodies in Tuberculosis
    Lu, Lenette L.
    Chung, Amy W.
    Rosebrock, Tracy R.
    Ghebremichael, Musie
    Yu, Wen Han
    Grace, Patricia S.
    Schoen, Matthew K.
    Tafesse, Fikadu
    Martin, Constance
    Leung, Vivian
    Mahan, Alison E.
    Sips, Magdalena
    Kumar, Manu P.
    Tedesco, Jacquelynne
    Robinson, Hannah
    Tkachenko, Elizabeth
    Draghi, Monia
    Freedberg, Katherine J.
    Streeck, Hendrik
    Suscovich, Todd J.
    Lauffenburger, Douglas A.
    Restrepo, Blanca I.
    Day, Cheryl
    Fortune, Sarah M.
    Alter, Galit
    [J]. CELL, 2016, 167 (02) : 433 - +
  • [27] First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
    Luabeya, Angelique Kany Kany
    Kagina, Benjamin M. N.
    Tameris, Michele D.
    Geldenhuys, Hennie
    Hoff, Soren T.
    Shi, Zhongkai
    Kromann, Ingrid
    Hatherill, Mark
    Mahomed, Hassan
    Hanekom, Willem A.
    Andersen, Peter
    Scriba, Thomas J.
    [J]. VACCINE, 2015, 33 (33) : 4130 - 4140
  • [28] Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv
    Mahmood, Anjum
    Srivastava, Shubhra
    Tripathi, Sarita
    Ansari, Mairaj Ahmed
    Owais, Mohammad
    Arora, Ashish
    [J]. FEBS JOURNAL, 2011, 278 (02) : 341 - 353
  • [29] Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv
    Malen, Hiwa
    Berven, Frode S.
    Fladmark, Kari E.
    Wiker, Harald G.
    [J]. PROTEOMICS, 2007, 7 (10) : 1702 - 1718
  • [30] Matsumoto Tomoshige, 2014, Kekkaku, V89, P743